查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387489

ELISA（酵素結合免疫吸附檢測法）市場報告：2030 年趨勢、預測與競爭分析

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

ELISA（酵素結合免疫吸附檢測法）的趨勢和預測

預計 2024 年至 2030 年，全球 ELISA 方法市場將以 7.5%的年複合成長率成長。該市場的主要促進因素是愛滋病毒、登革熱、肝炎、瘧疾、流感等感染疾病的流行以及面臨多種感染疾病風險的老年人口的增加。全球 ELISA 市場的未來前景廣闊，為醫院和診斷中心、製藥和生物技術公司、學術研究中心和臨床實驗室市場提供了商機。

ELISA 市場洞察

Lucintel 預測，由於攜帶性和持續的技術進步，多重/攜帶式 ELISA 將在預測期內實現最高成長。

在這個市場中，由於疾病盛行率不斷上升、對個人化醫療的需求不斷成長以及政府對 ELISA 方法的支持不斷增加，醫院和診斷中心仍將是最大的細分市場。

由於老年人口迅速成長、醫療設備普及不斷提高以及先進的醫療基礎設施的存在，北美在預測期內可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球ELISA 市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球 ELISA 市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球 ELISA 方法市場
    • 夾心ELISA
    • 間接ELISA
    • 多重/攜帶式 ELISA
    • 競爭ELISA
  • 按應用分類的全球 ELISA 市場
    • 免疫
    • 疫苗開發
    • 感染疾病
    • 癌症
    • 蛋白質定量
    • 其他
  • 按最終用途分類的全球 ELISA 方法市場
    • 醫院/診斷中心
    • 製藥和生物技術公司
    • 學術研究中心
    • 臨床實驗室
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球 ELISA 方法市場（按地區）
  • 北美ELISA市場
  • 歐洲ELISA市場
  • 亞太 ELISA 市場
  • 其他地區ELISA市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球 ELISA 方法市場成長機會
    • 按應用分類的全球 ELISA 市場成長機會
    • 按最終用途分類的全球 ELISA 方法市場成長機會
    • 按地區分類的全球 ELISA 方法市場成長機會
  • 全球 ELISA 市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球 ELISA 市場的產能
    • 全球ELISA市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • BioMerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories
簡介目錄

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Trends and Forecast

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

A more than 150-page report is developed to help in your business decisions.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Immunology
  • Vaccine Development
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Clinical Laboratories
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Biomerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Insights

Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Within this market, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.

North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

Q3. What are the major segments for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The future of the enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets.

Q4. Who are the key enzyme-linked immunosorbent assay (ELISA) tests market companies?

Answer: Some of the key enzyme-linked immunosorbent assay (ELISA) tests companies are as follows:

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Biomerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories

Q5. Which enzyme-linked immunosorbent assay (ELISA) tests market segment will be the largest in future?

Answer: Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Q6. In enzyme-linked immunosorbent assay (ELISA) tests market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 3.3.1: Sandwich ELISA
    • 3.3.2: Indirect ELISA
    • 3.3.3: Multiple and portable ELISA
    • 3.3.4: Competitive ELISA
  • 3.4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 3.4.1: Immunology
    • 3.4.2: Vaccine Development
    • 3.4.3: Infectious diseases
    • 3.4.4: Cancer
    • 3.4.5: Protein quantitation
    • 3.4.6: Others
  • 3.5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 3.5.1: Hospitals and Diagnostic Centers
    • 3.5.2: Pharmaceutical and Biotech Companies
    • 3.5.3: Academic Research Centers
    • 3.5.4: Clinical Laboratories
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 4.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.2.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.3: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.3.1: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.3.2: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.4: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.4.1: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.4.2: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.5: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.5.1: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.5.2: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 6.1.2: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 6.1.3: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 6.1.4: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 6.2: Emerging Trends in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ortho Clinical Diagnostics
  • 7.2: Thermo Fisher Scientific
  • 7.3: BioMerieux
  • 7.4: Sysmex Corporation
  • 7.5: F. Hoffmann-La Roche
  • 7.6: Danaher Corporation
  • 7.7: Quidel Corporation
  • 7.8: Bio-Rad Laboratories
  • 7.9: Siemens Healthineers
  • 7.10: Abbott Laboratories